Meeting Preview | The ‘White Paper on the Global Digital Intelligence Medical Imaging Industry Development in the AGI Era’ will be released during the Frost & Sullivan Life Science New Investment Summit Forum Medical Devices Session

The 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and 5th New Investment Conference (hereinafter referred to as '2026 Frost & Sullivan Summit' or 'Conference'), organized by Frost & Sullivan, a world-leading growth consulting firm, will be held grandly in Shanghai from August 4-5, 2026. During the conference, a new investment forum on Life Science will be launched. This forum includes three parallel sessions focusing on biomedicine, medical devices, and health technology, presenting cutting-edge topics and latest insights. With the core concept ‘Driving Change through Innovation, Staying Resilient and Achieving Long-Term Success’, the forum invites industry leaders, biomedicine and medical device companies, health technology firms, investment institutions, and professional service organizations to deeply discuss the latest trends in life science, innovative technologies, and global development paths, aiming to promote industrial upgrading and global collaboration.The 'White Paper on the Development of the Global Digital Intelligence Medical Imaging Ecosystem in the AGI Era' will be released during the Medical Devices session of the Frost & Sullivan Life Science New Investment Forum on August 5.

Host City: Shanghai, China

Date: August 4-5, 2026

Conference Scale: 5,000+

Format: Offline + Online Live Streaming

Organizer: Frost & Sullivan

Scan the QR code to register immediately

Healthcare is accelerating toward ‘data intelligence’

As artificial intelligence reshapes countless industries at an unprecedented pace, the healthcare sector is also undergoing a profound transformation from ‘experience-driven’ to ‘data intelligence’. Medical imaging involves the entire process of disease screening, clinical diagnosis, treatment planning, efficacy assessment, and follow-up management. It features high application frequency, large data volume, and clear clinical value, making it one of the key medical scenarios where artificial intelligence has achieved large-scale application first.

AI is reshaping the medical imaging ecosystem

In the past, AI medical imaging was mostly seen as the ‘second pair of eyes’ of radiologists, mainly responsible for lesion identification, abnormal detection, and auxiliary diagnosis. With the continuous development of base models, multimodal large models, and AI Agent technologies in medical imaging, AI is gradually extending to data governance, image analysis, structured reports, quality control, remote collaboration, and research translation. Its role has evolved from a single auxiliary tool to an important force in driving the digital intelligence evolution of the entire medical imaging ecosystem.

Building a Future-Ready Digital Intelligence Imaging Ecosystem and Development Path

This blue paper will start from the current construction status and real pain points of the medical imaging ecosystem, analyze the empowerment logic of AI in medical imaging services, clinical diagnosis, and ecosystem collaboration in the AGI era, and present relevant application practices in typical scenarios such as cranium, chest, and knee joints. On this basis, the blue paper further looks ahead to the future development path of the digital intelligence imaging ecosystem. Through this research, we hope to help the public and industry participants understand more intuitively the development of the medical imaging ecosystem, and how AI in medical imaging can truly become a partner and ‘digital doppelgänger’ in doctors' diagnosis and treatment processes.